Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers.
Brit S RohrEvelyn KrohmerKathrin I FoersterJuergen BurhenneMartin SchulzAntje BlankGerd MikusWalter Emil HaefeliPublished in: Clinical pharmacokinetics (2024)
EudraCT number: 2021-006643-39.